Fig. 2
From: Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
Net benefit curves for the risk prediction model of ER-positive tumors (ModelER+) (black solid line) and the Gail risk prediction model (ModelGail) (black broken line) applied to women from the Women’s Health Initiative study. Corresponding curves for the treat-all strategy are represented in gray (solid line for all breast cancer cases, broken line for ER+ tumors only). Area A = − 7.84 × 10-6; Area B = 1.08 × 10-5; Area C = 1.27 × 10-5